Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
78.08
-1.72 (-2.16%)
At close: Aug 28, 2026, 4:00 PM EDT
79.63
+1.55 (1.99%)
After-hours: Aug 28, 2026, 7:49 PM EDT

KNSA Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
840.85677.56423.24270.26220.1838.54
Revenue Growth
58.85%60.09%56.61%22.75%471.24%-
Gross Profit
458.3370.35234.02180.33173.2128.61
Operating Income
100.2577.22-45.62-25.29.77-156.64
Net Income
80.6659.01-43.1914.08183.36-157.92
Earnings Per Share
0.990.75-0.600.202.60-2.30
EPS Growth
1399.63%---92.31%--

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Product Revenue, Net
840.85677.56417.03233.18122.5238.54
License and Collaboration
--6.2137.0897.66-
Revenue (Total)
840.85677.56423.24270.26220.1838.54

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
525.93414.07243.63206.37190.61182.2
Total Debt
8.99.59.8612.265.926.05
Net Cash (Debt)
517.03404.58233.77194.11184.69176.15
Net Cash Growth
73.49%73.06%20.43%5.10%4.85%-44.34%
Net Cash Per Share
6.315.123.272.702.622.57

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
184.97137.9925.6913.35.81-126.3
Capital Expenditures
-2.13-1.57-0.28-0.13-0.11-0.42
Free Cash Flow
182.84136.4225.4113.175.7-126.71
Free Cash Flow Growth
174.98%436.82%92.94%130.99%--

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
54.50%54.66%55.29%66.72%78.67%74.22%
Operating Margin
11.92%11.40%-10.78%-9.32%4.44%-406.38%
Pretax Margin
13.59%13.12%-8.54%-6.16%5.01%-406.13%
Profit Margin
9.59%8.71%-10.21%5.21%83.28%-409.72%
FCF Margin
21.74%20.13%6.00%4.87%2.59%-328.75%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
78.8552.99-87.605.68-
Forward PE
54.8927.3242.93170.84170.84-
P/FCF Ratio
33.3222.9256.2093.67182.67-
PS Ratio
7.254.613.374.574.7321.04